The Medical Research Council (MRC) Protein Phosphorylation Unit at the University of Dundee has made a second major appointment within a week, having recruited Dr Matthias Trost as a new Programme Leader.
Dr Trost, who is currently working as a Research Associate at the Institute for Research in Immunology and Cancer, Montreal, Canada, will take up his post in Dundee in August. Born and brought up in Freiburg, Germany, he obtained a BSc in Chemistry from the University of Manchester in 1996 and a Diploma in Chemistry from the Albert-Ludwig University of Freiburg, in 2001.
He then carried out postgraduate research at the German Research Centre for Biotechnology in Braunschweig, from where he received a PhD in 2004. He moved to the University of Montreal in 2005 to carry out postdoctoral research and was promoted to Research Associate in 2007.
Commenting on his appointment and research programme Dr Trost said, "I am very excited and grateful to be appointed to the MRC Protein Phosphorylation Unit where I will be able to work among some of the best researchers in the world.
'The MRC Unit and the College of Life Science in Dundee offer a world-class research environment while keeping a very collegial atmosphere which will help me to establish fruitful collaborations. With my work, I will try to understand how pathogenic bacteria survive in the immune cells that are specialised in killing these microbes, by interfering with signalling cascades.
'I hope that my work will help us to identify molecular mechanisms of infectious diseases such as tuberculosis, and provide new drug targets in the future. On a personal level, my partner and I are looking forward to coming to Scotland as we have always enjoyed the beautiful landscapes and friendliness of the people.'
The appointment of Dr Trost represents the second major recruitment thatr the MRC Protein Phosphorylation Unit has announced recently. Last week it was confirmed that Dr Ian Ganley from the Memorial Sloan Kettering Cancer Center, New York, will take up a post as a Programme Leader within the Unit in August.
Commenting on the appointment of Dr Trost, Sir Philip Cohen, Director of the MRC Protein Phosphorylation Unit said, 'We are extremely pleased to have recruited Matthias.
'His research on how white blood cells prevent infection by 'eating' pathogenic bacteria when they invade the body is an extremely interesting and important topic, and his great expertise in the technology of mass spectrometry will enable Matthias to initiate important new research collaborations with other Programme Leaders in our Unit.'
This latest appointment means the MRC Protein Phosphorylation Unit now comprises 10 Programme Leaders and 130 scientific and support staff.
Dr Trost met his partner, Dr Katharina Trunk, when they were studying chemistry in Freiburg. Dr Trunk also holds a PhD in the life sciences, which she obtained at the Technical University of Braunschweig, Germany. She is currently working as a postdoctoral fellow at the Institute for Research in Immunology and Cancer in Montreal, Canada. The couple have a one-year-old son called Linus.
Dr Trost, who is currently working as a Research Associate at the Institute for Research in Immunology and Cancer, Montreal, Canada, will take up his post in Dundee in August. Born and brought up in Freiburg, Germany, he obtained a BSc in Chemistry from the University of Manchester in 1996 and a Diploma in Chemistry from the Albert-Ludwig University of Freiburg, in 2001.
He then carried out postgraduate research at the German Research Centre for Biotechnology in Braunschweig, from where he received a PhD in 2004. He moved to the University of Montreal in 2005 to carry out postdoctoral research and was promoted to Research Associate in 2007.
Commenting on his appointment and research programme Dr Trost said, "I am very excited and grateful to be appointed to the MRC Protein Phosphorylation Unit where I will be able to work among some of the best researchers in the world.
'The MRC Unit and the College of Life Science in Dundee offer a world-class research environment while keeping a very collegial atmosphere which will help me to establish fruitful collaborations. With my work, I will try to understand how pathogenic bacteria survive in the immune cells that are specialised in killing these microbes, by interfering with signalling cascades.
'I hope that my work will help us to identify molecular mechanisms of infectious diseases such as tuberculosis, and provide new drug targets in the future. On a personal level, my partner and I are looking forward to coming to Scotland as we have always enjoyed the beautiful landscapes and friendliness of the people.'
The appointment of Dr Trost represents the second major recruitment thatr the MRC Protein Phosphorylation Unit has announced recently. Last week it was confirmed that Dr Ian Ganley from the Memorial Sloan Kettering Cancer Center, New York, will take up a post as a Programme Leader within the Unit in August.
Commenting on the appointment of Dr Trost, Sir Philip Cohen, Director of the MRC Protein Phosphorylation Unit said, 'We are extremely pleased to have recruited Matthias.
'His research on how white blood cells prevent infection by 'eating' pathogenic bacteria when they invade the body is an extremely interesting and important topic, and his great expertise in the technology of mass spectrometry will enable Matthias to initiate important new research collaborations with other Programme Leaders in our Unit.'
This latest appointment means the MRC Protein Phosphorylation Unit now comprises 10 Programme Leaders and 130 scientific and support staff.
Dr Trost met his partner, Dr Katharina Trunk, when they were studying chemistry in Freiburg. Dr Trunk also holds a PhD in the life sciences, which she obtained at the Technical University of Braunschweig, Germany. She is currently working as a postdoctoral fellow at the Institute for Research in Immunology and Cancer in Montreal, Canada. The couple have a one-year-old son called Linus.